Bioniz
is a California-based biopharmaceutical company that researches and develops peptide therapeutics for the treatment of auto-immune and immune dysregulation diseases... Read moreBioniz
is a California-based biopharmaceutical company that researches and develops peptide therapeutics for the treatment of auto-immune and immune dysregulation diseases... Read more
News
Feb 17, 2022
Citybizlist
Bioniz: Equillium Acquires Bioniz Therapeutics
Feb 16, 2022
Benzinga
Bioniz: Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition
Feb 16, 2022
Pharmaphorum
Bioniz: Equillium triples clinical pipeline with $329m Bioniz takeover
Apr 06, 2021
PR Newswire
Press Release: Bioniz : Bioniz Therapeutics Receives Orphan Drug Designation from the European Commission for BNZ-1 for Treatment of Cutaneous T-Cell Lymphoma
Jan 04, 2021
PR Newswire
Press Release: Bioniz : Bioniz Announces Positive End of Phase 2 Meeting with the FDA for BNZ-1 for the Treatment of Refractory Cutaneous T-Cell Lymphoma
Dec 05, 2020
Markets Insider
Bioniz: Bioniz Announces Positive Clinical Data of BNZ-1, First Anti-Cytokine Therapy to Demonstrate Efficacy in Treating Refractory Cutaneous T-Cell Lymphoma
Nov 05, 2020
PR Newswire
Press Release: Bioniz : Bioniz Announces Oral Presentation at ASH 2020 of Positive Clinical Data of BNZ-1 for the Treatment of Refractory Cutaneous T-Cell Lymphoma
Jul 21, 2020
Pharmabiz
Bioniz: Bioniz announces positive data from phase 1/2 study of BNZ1 to treat cutaneous Tcell lymphoma
Jan 13, 2020
Orange County Business Journal
Bioniz: Bioniz Wins Spanish Investment
Jan 09, 2020
MarketScreener
Bioniz Therapeutics: Bioniz Therapeutics enters into an option agreement for acquisition by Almirall of its lead clinical candidate BNZ-1 in development for immuno-dermatologic and onco-dermatologic diseases
Bioniz Competitors
1
2
3
4
5
6
7
8
9
10